Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study
Christopher J Martoni,Amalie Kruse Sigersted Frederiksen,Anders Damholt,Gregory Leyer
DOI: https://doi.org/10.2147/IJWH.S341046
2022-01-18
Abstract:Christopher J Martoni, Amalie Kruse Sigersted Frederiksen, Anders Damholt, Gregory Leyer Chr. Hansen A/S, Human Health, Hoersholm, DK-2970, Denmark Correspondence: Christopher J Martoni Email Objective: To investigate the clinical effects of a 10-strain probiotic on parameters of vaginal health in a pilot, open label study in women with intermediate Nugent score (NS) or vaginal pH > 4.5. Methodology: A total of 43 healthy premenopausal women, ages 18 to 50 years, with NS of 4– 6 or vaginal pH > 4.5 were enrolled. Participants consumed a probiotic formulation (Feminine SupportTM), containing 8 lactobacilli and 2 bifidobacteria strains, with a daily dose of 2.5× 10 10 CFU for 28 (subgroup 1) or 42 (subgroup 2) days. Investigational visits occurred at day 0, 14, 28 and 42 with assessment of vaginal pH, NS and vaginal microbiota, via next-generation sequencing. Results: A total of 36 participants were included in the analysis set, with 24 and 12 participants included in subgroups 1 and 2, respectively. In the analysis set, there was a significant reduction in vaginal pH, from baseline, at day 28 (mean change=? 0.19, P = 0.047). Participants in subgroup 1 achieved a significant reduction in vaginal pH from baseline, at day 28 (mean change=? 0.23, P = 0.029) and day 42 (mean change=? 0.29, P = 0.008), while participants in subgroup 2 achieved a significant and quantitatively greater reduction in vaginal pH from baseline to day 42 (mean change=? 0.64, P = 0.008). No significant changes in NS were reported, due in part to highly diverse baseline levels. Vaginal microbial abundance exhibited a majority lactobacilli abundance at baseline, which was maintained over the study period. Vaginal pH was inversely associated with lactobacilli abundance throughout the study (P < 0.005). The product was well tolerated with high compliance. Two participants reported adverse events with suspected causality, which were mild and resolved during the study. Conclusion: This 10-strain probiotic formulation was well tolerated and helped reduce vaginal pH in women with intermediate NS or elevated vaginal pH. The study product warrants a randomized controlled trial to further assess efficacy. Keywords: probiotic, vaginal pH, Nugent score, vaginal microbiota, microbiome The human vaginal microbiome is unique among body sites, generally dominated by few bacterial species and characterized by low alpha diversity and high interindividual variability. 1 The vaginal microbiome is dynamic and influenced by different factors, including the phase of the menstrual cycle, use of contraceptives, douching, pregnancy, use of antibiotics, frequency of sexual intercourse and age. 2–5 In most healthy women, the vaginal microbiome is primarily dominated by lactobacilli, however, a proportion of asymptomatic, otherwise healthy individuals lack lactobacilli in appreciable numbers. 6 Lactobacilli are believed to preserve a healthy microbiota through various mechanisms. First, they generate lactic acid from the fermentation of glycogen produced by the vaginal mucosa, which plays an important role in protection against microbes due to reduction in vaginal pH. 2 Additionally, lactobacilli produce hydrogen peroxide and antimicrobial peptides (bacteriocins), preferentially adhere to vaginal wall cells and in some cases produce biosurfactants that prevent or attenuate the adherence of pathogens. 2,6,7 Vaginal microbiota dysbiosis, characterized by the loss of lactobacilli dominance and increase of microbial diversity, is closely related to gynecological diseases. 8 Among these, bacterial vaginosis (BV) is associated with an excessive growth of diverse, predominantly anaerobic bacteria including Gardnerella, Prevotella, Atopobium, Mobiluncus , and Sneathia , 9 as well as a decrease in lactic acid and hydrogen peroxide concentration resulting in an increase in vaginal pH. 10 BV is often diagnosed by a gram-stain based Nugent score (NS) of 7–10, 11 as well as via Amsel's criteria, point-of-care, 12 and more recently, molecular tests. 13 An intermediate NS of 4–6, while not BV, has been shown to be associated with increased vaginal epithelial exfoliation, 14 and incident trichomonal, gonococcal, and/or chlamydial infection. 15 BV is often treated with antibiotics such as clindamycin, metronidazole or dequalinium chloride, however various antibiotic treatments have been shown to also negatively impact the normal vaginal microbiota, 16–18 and may increase the risk of antimicrobial drug resistance. 19 Therefore, alternative and more effective treatments are needed to restore the vaginal microbiota. -Abstract Truncated-